ANNUAL REPORT 2008

PARAMOUNT BED CO., LTD.

Profile

Statement:

As Human, for Human
Paramount Bed Co., Ltd., founded in 1947, is a pioneer in the field of medical beds.
Using its own unique integrated production system, it has been providing products
designed not only to improve conditions for convalescing patients, but also to facilitate
the work of caregivers for more than half a century. With the aging of the Japanese
population, in recent years it has expanded its scope of business to cover facilities forthe elderly and home nursing care, developing home-care beds and various other types
of welfare equipment. These initiatives are in line with Paramount Bed’s goal of creatinga patient-friendly healthcare environment.
The Paramount Bed group consists of Paramount Bed and 10 consolidated subsidiaries
and 3 affiliated companies (as of March 31, 2008). In the fiscal year to March 2008, it had
net sales of ¥40,439 million, operating income of ¥1,587 million, and net income of ¥584
million. Paramount Bed is Japan’s leading maker of medical beds and has acquired astrong reputation, as reflected in its domestic market share of 70% (PB estimate).

Philosophy:
We integrate cutting-edge technology
with a human touch to create healthcare environments
offering comfort and ease.

Disclaimer Regarding Forward-Looking Statements
The information contained in this annual report is given for the sole purpose of providing information regarding the business performance ofParamount Bed Co., Ltd. during the fiscal year ended March 31, 2008, and is not intended to solicit investment in any securities issued by
the Company. Any statements with respect to Paramount Bed’s current plans, strategies, and forecasts are forward-looking statements
based upon information available as of March 31, 2008, and involve known and unknown risks and uncertainties. Actual events and results
may differ materially from those anticipated in these statements.

1

To Our Shareholders

We strive to create
a comfortable healthcare environment
with advanced technology andconsideration towards users.
Kenji Kimura
President and Representative Director

Thank you for your strong support for Paramount Bed.
The following are the general conditions of business andthe settlement of accounts for the 60th term of theCompany (from April 1, 2007 to March 31, 2008).

Earnings for the fiscal year ended
March 2008
For the fiscal year ended March 2008, the Company
posted consolidated net sales of ¥40,439 million (up12.6% year-on-year). Sales of domestic and overseas
subsidiaries that came under the wing of the Company
group contributed to the increased sales, although thedomestic market environment remained harsh, as it had
been in the previous fiscal year.
Operating income soared 88.7% year-on-year to¥1,587 million thanks to rationalization and other factors.
However, ordinary income declined 37.7% from theprevious fiscal year to ¥1,833 million owing to adecrease in financial income, which had grownsignificantly during the previous fiscal year. Net income
amounted to ¥584 million, against a net loss of ¥2,033
million in the previous fiscal year.
For the dividend payments for the fiscal year ending
March 2009, we plan to disburse ¥15 per share to ourshareholders as both interim and year-end dividends,
unchanged from the current fiscal year.

Reinforcement of overseas operations andpromotion of new businesses
The Company has implemented the following measuresin the past two years by focusing on the reinforcement ofoverseas operations and the promotion of new
businesses, as well as deepening existing businesses,
amid radical changes in the business environment.
The Company purchased Corona Medical S.A.S., a
French manufacturer of medical beds, in December 2006,
securing a manufacturing and sales base in Europe. To
mutually supplement products with Hill-Rom, Inc., thelargest manufacturer of medical beds in the U.S., westarted importing and marketing high-performance beds
from Hill-Rom in September 2007. Currently preparations
are under way for the marketing of our beds for nursing
care at home or in facilities for the elderly in the U.S.
With regard to new businesses, the Company madeSunnetwork Corporation, engaged in rental service andwholesale of welfare devices, its subsidiary in October
2007. We will strive to bolster earnings by pursuingsynergy between manufacturers and distributors. We
also inaugurated a new organization to enhance thebusiness for general consumers, with the INTIME brandas its core.
We will endeavor to steadily advance these measuresand make them bear fruit in and after the next fiscal year.

Enhanced competitiveness by
restructuring plants
The Company has been pushing forward with a plan toreorganize domestic plants since fiscal 2006. An
integrated production line based on thesynchronous/tuned production method, which raises
productivity dramatically, was completed at the Chiba
Plant and came on stream in May 2008.
The new production line has not only realized higher
efficiency but is also environmentally friendly, with a 60%
reduction in industrial waste and a 30% cut in electricity
consumed by painting equipment.
The Chiba Plant will play the role of a “mother plant”
for overseas production bases in Indonesia, China, andFrance, as well as those in Japan.
July 2008

Kenji Kimura
President and Representative Director2Topics

Integrated production line completed in Chiba Plant,
aiming for more efficient production
The Company consolidated the functions of the Ohira Plant, one of thethree plants in Chiba Prefecture (Chiba, Ohira and Matsuo Plants), into the
Chiba Plant, and installed an integrated production line based on thesynchronous/tuned production method at the Chiba Plant. Regular
operation started in May 2008.
The previous production method required five days from welding to
the completion of assembly, as the different stages of the products weremade in advance and kept stored together for one day between each of
the three processes of welding, painting and assembly. All the processes

View of Chiba Plantof the newly introduced synchronous production line, which does notmake any products in advance or store them together between
processes, finish in about six hours for beds for medical facilities andfacilities for the elderly. Meanwhile, the tuned production line, which canhandle small-lot production of a wide variety of products, turns out

Integrated production line process

products keeping liquid inventories of about two hours between
processes.
Under the reorganization plan, aimed at facilitating production, we
launched the integrated production line project in July 2006 and started
improvement in June of the following year. The new production line has
recently been completed and started regular operations.

Good Design Awards 2007
INTIME7000 Series electric adjustable bed, andKB-115 and KB-116 beds for infants
The INTIME7000 Series electric adjustable beds and the KB-115 andKB-116 beds for infants were awarded the Good Design Awards 2007 on
October 1, 2007.
In the process of screening, the INTIME7000 Series was highly evaluatedin such areas as “easy to use and kind to the user” and “creation of nextgeneration lifestyle,” while the KB-115 and KB-116 were appreciated fortheir “original, formative expression” and other characteristics.

KB-116
GOOD DESIGNAWARD 2007

INTIME7000 Series3

KB-115

Major Overseas Subsidiaries

PT.PARAMOUNT BED INDONESIA
Address:

Bekasi, Jawa Barat, Indonesia

Capital:

9,036 million rupiah

Establishment:

September 1995

Business:

Manufacture and sale of medical andnursing-care beds and other products.

Number of Employees:

177

Net sales in previous year: 12,356 thousand U.S. dollars

PARAMOUNT BED CHINA
Address:Wuxi, Jiangsu, China

Capital:

8 million U.S. dollars

Establishment:

March 2004

Business:

Manufacture and sale of medical andnursing-care beds and other products.

Number of Employees:

65

Net sales in previous year: 53,883 thousand yuan

CORONA MEDICAL S.A.S.
Address:

Rochecorbon, France

Capital:

675 thousand euros

Establishment:

October 2001

Business:

Manufacture and sale of medical andnursing-care beds and other products.

Number of Employees:

128

Net sales in previous year: 25,921 thousand euros
Notes 1: CORONA SARL, the forerunner of CORONA MEDICAL S.A.S., was established in 1954.
2: In June, 2007, the Company acquired and merged with Corbon Holdings S.A.S.

4

Product Lineup
Hospital beds

Beds for elderly-care facilities

Beds must provide safety, comfort and ease of operation.
Our hospital bed line offers a full range, from sophisticatedto standard models. The SO-7000 is a high quality nursingcare bed that features sophisticated functionality anddesign. Its robust, high-quality manufacture supports
modern medical care.

Falling out of bed can be a cause ofserious injury for residents of elderly-carefacilities. Our ultra-low Callisto Series beds
reduce the risk of harm in the event of afall. (Photo shows bed fitted with Thestor
shock-absorbing mattress)

Acute care (for special rooms)

Advanced, emergency use

Callisto series

SO-7000

KA-8560

Woody series

Metis series

Pediatric bed, Bassinet cart
KA-8010 A

Transfer Stretcher Trolley
The Stretcher Trolley transfers patients safely,
helping nurses and reassuring patients.

The Pediatric Bed (KB-655) is equipped with many functions to ensure
safety and operability, and is friendly to both children and nurses.
The Bassinet Cart (KB-115, 116) is user-friendly for both newborn infants
and their mothers. Its design, developed with the image of a young leaf inmind, gives newborns a sense of security as if they were wrapped up
inside it. Green is suitable for both boys and girls and is said to be effective
in calming people and softening their mood. The design of the Bassinet
Cart has been highly evaluated, and won the Good Design Award 2007.

KB-655
KK-728

5

KB-115, 116

Beds for the home (INTIME)
Everyone spends time in bed, and the
INTIME models are designed to facilitate
deep, refreshing sleep.

Home-care products
Demand for rental home-care beds hasgrown rapidly since the start of thenursing-care insurance program. The
Rakusho Series is designed to cater tothe varied needs of different users.
The Scot-klean (Uri-comfort) is a urine
collector that automatically activateswhen it detects the presence of urine.

INTIME 7000 series

Bed peripherals
Mattresses
With elasticity similar to the human body’s,
the Ever Fit reduces the resistanceproduced when users turn over on the bed
and it also stabilizes the posture during
sleep.
The mattress is reversible and both sides
have different functions that users canchoose to suit their condition, build andpreference.
We also offer the versatile Preglar Matress,
for use in hospitals, elderly-care facilities,
and home care.

Style Port
Ever Fit mattress

Preglar mattress
Rakusho series

Other Products
These products are based on original concepts developed byParamount Bed. We also offer a wide range of bed peripherals,
such as drip stands, designed to maximize usability.

Scot-klean (Uri-comfort)
Swing arm assist bar

Nursing Wagon

Patient Lifter

I.V. Stand

6

Consolidated Balance Sheets
Paramount Bed Co., Ltd. and Subsidiaries — March 31, 2008 and 2007

Millions of yen

ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Notes and accounts receivable—tradeMarketable securities
Inventories
Other
Total current assets

2008¥

11,505
14,302
6,094
3,763
1,161
36,826

Thousands of U.S. dollars

2007
¥

2008

7,217
14,529
9,061
4,725
1,310
36,845$ 114,832
142,749
60,82437,55911,588367,562

NON-CURRENT ASSETS:
Property, plant and equipment
Intangible assets
Investment and other assets
Total non-current assets
Total assets

22,8803,628
14,863
41,372
78,19821,7483,105
14,77839,63276,478228,366
36,211
148,348
412,935
780,497

LIABILITIESCURRENT LIABILITIES:
Notes and accounts payable—trade
Other current liabilities
Total current liabilities

5,653
5,611
11,265

5,764
3,234
8,999

56,42356,004112,436

LONG-TERM LIABILITIES:
Total liabilities

2,845
14,111

1,969
10,96828,396140,842NET ASSETSSHAREHOLDERS’ EQUITY:
Common stock
Capital surplus
Retained earnings
Treasury stock
Total shareholders’ equity

6,591
7,276
53,151(3,537)63,482

6,591
7,276
53,783(3,533)64,11865,78572,622
530,502(35,303)
633,616

452
2
454

1,130
161
1,291

4,511
20
4,531

150
64,087
78,198100
65,50976,478

1,497
639,655$ 780,497

VALUATIONS AND ADJUSTMENTS:
Unrealized gain on available-for-sale securities
Foreign currency translation adjustments
Total valuations and adjustments
Minority interests
Total net assets
Total liabilities and net assets¥¥

Note: The approximate exchange rate in effect on March 31, 2008 was ¥100.19 = U.S.$1.

Business Review in Fiscal 2008
In the healthcare industry, while a serious shortage ofphysicians and the reduction and closure of key regional
hospitals became apparent under the government’s strictmeasures to curb medical fees, facility requirements were
decided for new-type geriatric medical and health carefacilities, which are facilities that will use long-term carebeds, and this will be the core of realignment of hospitalbeds in the future.
On the other hand, in the sector of welfare for the elderly,
the market for welfare device rental services, which dwindled
at a stroke because of a revision of the nursing-careinsurance law in April 2006, has finally bottomed out and has
been picking up gradually.
In this business environment, the Company groupincreased its capital investment and focused on research anddevelopment activities in order to bolster earnings.
In its major capital investments, the Company built a new
integrated production line at the mainstay Chiba Plant in a bid
to consolidate domestic plants and reform the production
setup, and put it into regular operation in May 2008.
With respect to the development and sales of products,
the Company fully remodeled products such as the Scot-

7

klean (Uri-comfort) automatic urine collector and folding bed
side rails, and it also developed Sleep Scan, a system todetermine whether someone is asleep, with a view tocommercializing it at an early stage.
In the area of new businesses, the Company madeSunnetwork Corporation (head office in Shizuoka City),
engaged in rental services and wholesale of welfare devices,a subsidiary, and formed a sales alliance with Hill-Rom, Inc.,the largest manufacturer of hospital beds in the U.S.
As for our overseas operations, overseas net sales
topped 10% of the consolidated net sales for the first time,
mainly thanks to a conclusion of an export contract for
Mexico, which is one of the largest export contracts we havesigned, and sales chalked up by Corona Medical S.A.S ofFrance, which became a subsidiary in the previous fiscal
year.
In the fiscal year under review, looking at the sales bytype of user (on a non-consolidated basis), sales related tonursing-case facilities dropped by 8.0% year-on-year
primarily because of sluggish sales to facilities for the elderly,
as was the case in the previous fiscal year, while sales ofhome-care products increased by 9.8% year-on-year, as theConsolidated Statements of Operations
Paramount Bed Co., Ltd. and Subsidiaries — Years Ended March 31, 2008 and 2007

Millions of yen

2008
Net sales

Thousands of U.S. dollars

2007
35,927$ 403,623

26,35723,540263,070

14,082

12,387140,553

12,494

11,546

124,703

1,587

841

15,840

Other income

765

2,113

7,635

Other expenses

518

12

5,170

Ordinary income

1,833

2,942

18,295Extraordinary income

157

145

1,567

Extraordinary loss

764

5,447

7,626

1,226

(2,359)12,237¥

Cost of sales
Gross profit
Selling, general and administrative expenses
Operating income

Income (loss) before income taxes and minority interests

40,439¥2008

Income taxes:
Current

321

61

3,204

Deferred

307

(348)

3,064

(12)

38

Minority interests in net loss (gain)
Net income (loss)

¥

584

¥

(2,033)

(120)
$

5,829

Consolidated Statements of Cash Flows
Paramount Bed Co., Ltd. and Subsidiaries — Years Ended March 31, 2008 and 2007

Millions of yen

2008
Net cash provided by (used in) operating activities

¥

5,765

Thousands of U.S. dollars

2007
¥

2008

(1,353)$57,541

Net cash used in investing activities(1,289)(1,997)(12,866)

Net cash used in financing activities(1,435)(1,525)(14,323)

(64)

55

(639)

2,977

(4,820)29,714Foreign currrency translation adjustments on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

10,426¥

13,403¥

15,247104,062

10,426$ 133,776

Note: The approximate exchange rate in effect on March 31, 2008 was ¥100.19 = U.S.$1.

market finally bottomed out after having dwindled sharply
following a revision of the nursing-care insurance law in theprevious fiscal year.
Sales by major product category for the fiscal year underreview were as shown in the graph below.
As a result, consolidated net sales for the fiscal year
under review grew by 12.6%, or ¥4,511 million, year-on-yearto ¥40,439 million, primarily because sales of Corona Medical
S.A.S. of France were added.
Operating income jumped 88.7% year-on-year to ¥1,587
million thanks to the effect of rationalization (at the parent),
implemented in the previous fiscal year, and expansion of
earnings of consolidated subsidiaries. Ordinary income fell by
37.7% year-on-year to ¥1,833 million because of the
reduction of financial income, which increased significantly inthe previous fiscal year. Net income amounted to ¥584 million(against a net loss of ¥2,033 million in the previous fiscal
year) thanks to a plunge in extraordinary losses in the current
fiscal year. In the previous fiscal year, extraordinary losses ofapproximately ¥5,400 million were posted, including premium
severance payment for voluntary retirees.
Geographic segment earnings are as follows. Net sales

and operating income/loss of each geographic segment
include internal transactions between segments.
Net sales of ¥36,891 million and operating income of¥1,368 million were posted for Japan. Net sales amounted to¥2,118 million and operating income stood at ¥249 million in
Asia, while net sales of ¥4,320 million and operating loss of¥201 million were posted for Europe.
Finally, Ryusuke Kimura, the founder and honorary
chairman of the Company, passed away on August 4, 2007,at the age of 89.

Sales by major product category
Hospital-use furniture
4,113 (10.2%)
Medical-use products
2,364 (5.8%)

Millions of yen

Mattresses
2,617 (6.5%)

Total

40,439

Beds
20,113 (49.7%)

Other
11,229 (27.8%)8

Consolidated Statements of Changes in Net Assets
Paramount Bed Co., Ltd. and Subsidiaries — Years Ended March 31, 2008 and 2007

Shareholders’ Equity

Millions of yen

CommonStockCapitalSurplusRetained
Earnings

Valuations and Adjustments
Unrealized
Foreign
Total
Total
Gain onCurrency Valuations
Treasury Shareholders’ Available-for-sale Translation
andMinority
Total
Stock
EquitySecurities Adjustments Adjustments Interests Net Assets

Balance, March 31, 2007

¥ 6,591¥ 7,276¥ 53,783¥ (3,533) ¥ 64,118(1,216)(1,216)(1,216)

584

584

(3)

(3)

¥ 1,130¥161¥ 1,291¥100¥ 65,509

Changes of items during
the current fiscal year
Cash dividends
Net income584

Acquisition of treasury stock(3)

Net changes of items other thanshareholders’ equity

(678)

(158)

(836)

49

(786)

(678)

(158)

(836)

49

(1,422)150¥ 64,087

Total changes of items during
the current fiscal period

—

—

(632)

Balance, March 31, 2008

¥ 6,591¥ 7,276¥ 53,151

(3)

(635)

¥ (3,537) ¥ 63,482

¥

452

¥

2

¥

454

¥

Shareholders’ Equity

Thousands of U.S. dollars

CommonStockCapitalSurplusRetained
Earnings

Valuations and Adjustments
Unrealized
Foreign
Total
Total
Gain onCurrency Valuations
Treasury Shareholders’ Available-for-sale Translation
andMinority
Total
Stock
EquitySecurities Adjustments Adjustments Interests Net Assets

Balance, March 31, 2007

$ 65,785$ 72,622$536,810$ (35,263) $639,964

Cash dividends(12,137)(12,137)(12,137)

Net income

5,829

5,829

5,829

(30)

(30)

$ 11,279$ 1,607$ 12,886$

998$653,848

Changes of items during
the current fiscal year

(30)

Acquisition of treasury stock
Net changes of items other than

(6,767)(1,577)(8,344)489(7,845)(6,338)(6,767)(1,577)(8,344)489(14,193)$ (35,303) $633,616$ 4,51120$ 4,531$ 1,497$639,655

shareholders’ equity
Total changes of items during
the current fiscal period——(6,308)

Balance, March 31, 2008

$ 65,785$ 72,622$530,502(30)$

Note: The approximate exchange rate in effect on March 31, 2008 was ¥100.19 = U.S.$1.

Financial Highlights
Net sales

Millions of yen

Ordinary income

Millions of yen

8,146
60,0008,000

47,89450,61651,01145,00035,92740,439

7,259

6,734

6,000

30,0004,000

15,000

2,000

2,942
1,833

0

0

2004

2005

2006

2007

Net income (loss)
6,000

Millions of yen

2006

2007

2008

Net income (loss) per shareYen

162.38131.87

3,782

4,000

2005

200

5,140
4,182

2004

2008

120.61100
2,000(2,033)0584(66.83)(100)(3,000)

2004

9

19.22

0

2005

2006

2007

2008

2004

2005

2006

2007

2008

Corporate Information
As of March 31, 2008

Corporate Data

Network
Domestic

Corporate Name:
Head Office:Establishment:
Capital:Number of Employees:

Paramount Bed Co., Ltd.
14-5, Higashisuna 2-chome, Koto-ku,
Tokyo 136-8670, JapanMay 1950¥6,591 million
796

Board of Directors and Corporate Auditors(As of June 27, 2008)
President and Representative Director:
Vice-president and Representative Director:

Kenji Kimura
Kyosuke Kimura

Directors:

Michihide Kimura
Tadaharu Kato
Ikuo Sakamoto
Toshio Horiuchi
Hirokatsu Tokuda

Standing Corporate Auditors:

Katsuhiro Shibata
Yasunobu Furutani

Corporate Auditors:

Etsuji Ikegami
Yukari Oka

Shareholder Information
Authorized Shares:
Issued Shares:
Number of Shareholders:

126,000,000
31,682,526
17,223Major Shareholders
Number of Shares Percentage of
Owned (Thousands) Voting Rights (%)

Kimura Kosan Co., Ltd.
Kenji Kimura
Kyosuke Kimura
Mizuho Bank, Ltd.
Michihide Kimura
Ryusuke Kimura
CB London Stichting Pensioenfonds Zorg en Welzijn
Northern Trust Company (AVFC) Sub-account American Client
The Kimura Foundation for Nursing Education
State Street Bank and Trust Company

6,607
2,535
1,913
1,203
1,195
669
640
581
570
520

21.8
8.4
6.3
4.0
3.9
2.2
2.1
1.9
1.9
1.7

Note 1: The Company holds 1,264 thousands shares of treasury stock, but is excluded
from the above major shareholders.
Note 2: Ryusuke Kimura, a shareholder mentioned above, passed away on August 4,
2007. Registration of transfer of shares held in his name was not completed asof March 31, 2008.
Note 3: We received a copy of a change report dated October 2, 2007 concerning
massive shareholdings from Tradewinds Global Investors, LLC, to the purportthat the company held 1,955 thousand shares as of September 26, 2007.
However, Tradewinds Global Investors is excluded from the above major
shareholders since the Company cannot confirm the number of shares actually
held by the shareholder as of the end of the current fiscal year.

Ownership among Shareholders
Number of Shares Percentage of Total
Owned (Thousands) Shares Issued (%)

Financial institutions
Securities firms
Foreign corporations
Other domestic corporations
Individuals and others
Treasury stock

3,802
115
4,454
7,889
14,154
1,264

12.0
0.4
14.0
24.9
44.7
4.0

Head Office14-5, Higashisuna 2-chome, Koto-ku, Tokyo 136-8670
Tel. +81-3-3648-1111 (key number)Tel. +81-3-3648-2961 (Overseas Trade Division)
Branches
SapporoBranch●318-11, Nishi 13-chome, Minaminijo, Chuo-ku, Sapporo,
Hokkaido 060-0062
Tel. +81-11-271-1181● Sendai Branch
3-3, Oroshi-machi 2-chome, Wakabayashi-ku, Sendai, Miyagi 984-0015
Tel. +81-22-239-5211● Saitama Branch
4-7, Kamiochiai 9-chome, Chuo-ku, Saitama, Saitama 338-0001
Tel. +81-48-852-0707● Yokohama Branch
1715-1, Tsuruma, Machida, Tokyo 194-0004
Tel. +81-42-795-8800● Nagoya Branch
20-17, Izumi 1-chome, Higashi-ku, Nagoya, Aichi 461-0001
Tel. +81-52-963-0600● Osaka Branch
3-33, Tosabori 2-chome, Nishi-ku, Osaka, Osaka 550-0001
Tel. +81-6-6443-8791● Hiroshima Branch
8-5, Yokogawa-cho 3-chome, Nishi-ku, Hiroshima, Hiroshima 733-0011
Tel. +81-82-293-1311● Fukuoka Branch
14-20, Hakataeki-higashi 3-chome, Hakata-ku, Fukuoka,
Fukuoka 812-0013
Tel. +81-92-461-1131
Satellite● Takamatsu Satellite
223-1, Goto-cho, Takamatsu, Kagawa 761-8031
Tel. +81-87-881-8800
INTIME Shops● INTIME Kyobashi
Sumitomo Mitsui Hull Tepco Bldg.1F
6-1, Kyobashi 1-chome, Chuo-ku, Tokyo 104-0031
Tel. +81-3-5250-1515● INTIME Sapporo
1-4, Nishi 5-chome, Kitayojo, Chuo-ku, Sapporo, Hokkaido 060-0004
Tel. +81-11-219-8800● INTIME Nagoya
Address: Same as Nagoya Branch
Tel. +81-52-963-6800● INTIME Shinsaibashi
Sanei Shinsaibashi Bldg.1F
13-15, Nishishinsaibashi 1-chome, Chuo-ku, Osaka, Osaka 542-0086
Tel. +81-6-6245-9021● INTIME Fukuoka
Address: Same as Fukuoka Branch
Tel. +81-92-461-0666Plants● Chiba Plant
2078, Shirahata, Sanmu-shi, Chiba 289-1306
Tel. +81-475-82-6111● Matsuo Plant
617, Kashikehongo, Matsuo-machi, Sanmu-shi, Chiba 289-1537
Tel. +81-479-86-3331● Ohira Plant
690-1, Shimonogo, Matsuo-machi, Sanmu-shi, Chiba 289-1536
Tel. +81-479-86-2121
Subsidiaries● PARA TECHNO Co., Ltd.
1648-7, 1-chome, Kaijincho-minami, Funabashi, Chiba 273-0024
Tel. +81-47-431-0552● Sunnetwork Corporation
4-B, Kohara Southside Bldg., 2-2-1, Inagawa, Suruga-ku, Shizuokashi, Shizuoka 422-8062
Tel. +81-54-203-7711

Overseas

Representative Office● Shanghai Representative Office

Suite 1105, Liu Lin Tower, No.1 Huai Hai Middle Road, Shanghai
20021, P.R. China
Tel. +86-21-5383-5111● Representative Office in Paris
6, Rue de Remusat, 75016 Paris, France
Tel. +33-6-09-841-507
Subsidiaries● PT. Paramount Bed Indonesia
MM2100 Industrial Town, Block M-1-1, Export Processing Zone,
Cikarang Barat, Bekasi 17520, Jawa Barat, Indonesia
Tel. +62-21-8980715● Paramount Bed (China) Co., Ltd.
A-105, Wuxi National Hi & New Tech Industrial Developement Zone,
Wuxi, Jiangsu, China
Tel. +86-510-8532-3201● Corona Medical S.A.S.
Z.I. La Planche-37210 Rochecorbon, France
Tel. +33-2-47-885-885

10

Paramount Bed Co., Ltd.
14-5, Higashisuna 2-chome,
Koto-ku, Tokyo 136-8670, Japan
Tel. +81-3-3648-1111
http://www.paramount.co.jp
Printed in Japan